bf/NASDAQ:VIRI_icon.jpeg

NASDAQ:VIRI

Virios Therapeutics, Inc.

  • Stock

0.15

+12.40%

0.02

USD last updated 14/08 01:46:41

Last Close

0.14

08/10 20:00

Market Cap

7.13M

Beta: 1.93

Volume Today

42.36M

Avg: 2.87M

PE Ratio

−1.08

PFCF: −1.11

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-06-302020-09-302021-08-122022-11-142024-02-292025-05-07

    Revenue (Estimate*)

    0.000.000.010.010.012019-06-302020-09-302021-08-122022-11-142024-02-292025-05-07

    *Estimate based on analyst consensus